Matthew Osborne

Mr. Matthew S.
Osborne was previously employed as an Investor Relations by Apple Tree Venture Management Llc//vc, a Chief Financial Officer by Senda Biosciences, Inc., a Chief Financial Officer by Oncxerna Therapeutics, Inc., a Chief Financial Officer by Unum Therapeutics, Inc., a Chief Financial Officer by Unum Therapeutics, Inc., a VP-Investor Relations & Corporate Communications by Voyager Therapeutics, Inc., a Head-Investor Relations by Shire Plc, a Vice President-Investor Relations by Synageva BioPharma Corp., a Vice President by FM Partners Holdings LLC, an Associate Analyst by SVB Securities LLC, a Vice President by C.
E.
Unterberg, Towbin, Inc., a Salesman by Genzyme Corp., and a Head-Investor Relations by Vertex Pharmaceuticals, Inc. He received his undergraduate degree from Syracuse University and an MBA from D'Amore-Mckim School of Business.